Ergoteles’s Chimerix, Inc. CMRX Stock Holding History

Ergoteles’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-55,666	Closed	-$67.4K	–	898
2023 Q2	$67.4K	Buy	+55,666	New	+$70.5K	﹤0.01%	938
2022 Q2	–	Sell	-14,100	Closed	-$65K	–	2070
2022 Q1	$65K	Buy	+14,100	New	+$78.6K	﹤0.01%	1147

Other funds holding CMRX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ergoteles's CMRX Position: Q3 2023 in Review

Ergoteles sold out of Chimerix, Inc. (CMRX) in Q3 2023, closing a stake of 55,666 shares — an estimated $67.4K sold.

Ergoteles first reported a position in CMRX in Q1 2022 and held it in 2 quarters. The position peaked at $67.4K in Q2 2023. 78 funds tracked by Wall St. Rank hold CMRX as of Q3 2023.

Ergoteles reported no remaining Chimerix, Inc. position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 55,666 Chimerix, Inc. shares in Q3 2023, an estimated $67.4K.
Ergoteles first reported a position in Chimerix, Inc. in Q1 2022 and held it in 2 quarters.
Ergoteles's Chimerix, Inc. position peaked at $67.4K in Q2 2023.
78 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.